Frank Rimerman Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Frank Rimerman Advisors's BMY Position: Q3 2026 in Review
Frank Rimerman Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.11% in Q3 2026, buying an estimated $3.35K and bringing the position to 50,343 shares worth $3.14M. The position accounts for 0.17% of the portfolio, ranked #93.
Frank Rimerman Advisors first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Frank Rimerman Advisors held 50,343 shares of Bristol-Myers Squibb worth $3.14M as of Q3 2026.
- Frank Rimerman Advisors bought 53 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.35K.
- Bristol-Myers Squibb made up 0.17% of Frank Rimerman Advisors's portfolio in Q3 2026, its #93 holding.
- Frank Rimerman Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.